Showing 1 - 6 results of 6 for search 'Ahmed Aljabri', query time: 0.03s Refine Results
  1. 1
    Smart wearable sensor-based model for monitoring medication adherence using sheep flock optimization algorithm-attention-based bidirectional long short-term memory (SFOA-Bi-LSTM)

    Smart wearable sensor-based model for monitoring medication adherence using sheep flock optimization algorithm-attention-based bidirectional long short-term memory (SFOA-Bi-LSTM) by Yasser Alatawi, Palanisamy Amirthalingam, Narmatha Chellamani, Manimurugan Shanmuganathan, Mostafa A. Sayed Ali, Saleh Fahad Alqifari, Vasudevan Mani, Muralikrishnan Dhanasekaran, Abdulelah Saeed Alqahtani, Ahmed Aljabri

    Published 2025-06-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    The potential adding therapeutic effect of pentoxifylline and/or folic acid for chronic kidney disease patients: randomized controlled trial

    The potential adding therapeutic effect of pentoxifylline and/or folic acid for chronic kidney disease patients: randomized controlled trial by Amira Reda Muhammad Galal, Nahla Mohamed Teama, Karema Abu–Elfotuha, Ahmed D. Alatawi, Hanan Alshareef, Ahmed M. E. Hamdan, Ahmed Aljabri, Mohannad Alshibani, Zeinab AlKasaby Mahmoud Zalat

    Published 2025-08-01
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Association of Demographic Variables with the Awareness of Type 2 Diabetes Mellitus Patients (T2DM) among the Northwest Population in Saudi Arabia

    Association of Demographic Variables with the Awareness of Type 2 Diabetes Mellitus Patients (T2DM) among the Northwest Population in Saudi Arabia by Wael Ahmed Al Arawi, Udai Salamh Al Shaman, Waleed Ahmad Mohsin Albalawi, Palanisamy Amirthalingam Siddhachettiar, Sherif M. H. El-kannishy, Alaa Bagalagel, Reem Diri, Ahmed Aljabri, Ahmed Mohsen Hamdan

    Published 2020-01-01
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    Descriptive Analysis of Reported Adverse Events Associated with Vitiligo Medications Using FDA Adverse Event Reporting System (FAERS) Databases 2013–2023

    Descriptive Analysis of Reported Adverse Events Associated with Vitiligo Medications Using FDA Adverse Event Reporting System (FAERS) Databases 2013–2023 by Saleh F. Alqifari, Musaab Habibulla Gari, Jeff J. Guo, Shoroq Alamin, Aya K. Esmail, Abdullah K. Esmail, Heba R. Hamad, Ahmed Aljabri, Amirah M. Alatawi, Laila A. Albishi, Mohammed Olaythah Alraddadi, Helal F. Hetta

    Published 2025-07-01
    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    Effect of COVID-19 on hematological parameters and subsequent risk of anemia and bleeding in middle-aged and elderly patients with type 2 diabetes

    Effect of COVID-19 on hematological parameters and subsequent risk of anemia and bleeding in middle-aged and elderly patients with type 2 diabetes by Abdulazez N. Alqhtani, Shemah S. AlHwiti, Hind M. AlAtwi, Aeshah H. AlBuhayri, Abdulrazaq S. AlMasoudi, Saad F. AlShamari, Hind M. Alaidi, Abdullah M. S. Alshehri, Nouf A. Alanazi, Ahmed Aljabri, Mohannad Alshibani, Mohammed M. H. Al-Gayyar

    Published 2025-07-01
    Get full text
    Article
    Save to List
    Saved in:
  6. 6
    Effects of previous steroid treatment on ischemic stroke outcomes: a propensity score-matched hospital analysis

    Effects of previous steroid treatment on ischemic stroke outcomes: a propensity score-matched hospital analysis by Yasser Alatawi, Eman A. Alraddadi, Eman A. Alraddadi, Abdullah A. Alhifany, Faisal E. Alzahrani, Faisal E. Alzahrani, Saud M. Alknawy, Saud M. Alknawy, Nawaf M. Aljohani, Nawaf M. Aljohani, Husun K. Kecheck, Husun K. Kecheck, Alanoud K. Alaslab, Alanoud K. Alaslab, Aser F. Alamri, Aser F. Alamri, Ahmed Aljabri, Daniyah A. Almarghalani, Daniyah A. Almarghalani, Faisal F. Alamri, Faisal F. Alamri

    Published 2025-06-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: